Ambler, PA, United States of America

Jocelyn Leu

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Ambler, PA (US) (2019 - 2021)
  • Spring House, PA (US) (2020 - 2022)

Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Inventor Jocelyn Leu

Introduction

Jocelyn Leu is an accomplished inventor based in Ambler, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 4 patents to his name, Leu's work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Nucleic acids encoding anti-CD154 antibodies." This invention relates to antagonistic antibodies that specifically bind to CD154, along with polynucleotides encoding these antibodies or fragments, and methods for their production and use. Another notable patent is the "Method for treating pre-type 1 diabetes in a human subject." This invention focuses on compositions and methods utilizing anti-TNF antibodies, which include a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37, aimed at treating or preventing Type I Diabetes (T1D).

Career Highlights

Jocelyn Leu is currently associated with Janssen Biotech, Inc., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Leu collaborates with talented professionals in his field, including Joseph Hedrick and Elizabeth C Hsia, who contribute to his research and development efforts.

Conclusion

Jocelyn Leu's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the medical field. His innovative work continues to pave the way for advancements in treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…